Sands Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $479M | Buy |
|
|||||
|
2020
Q2 | $524M | Buy |
|
|||||
|
2020
Q1 | $410M | Sell |
|
|||||
|
2019
Q4 | $320M | Sell |
|
|||||
|
2019
Q3 | $247M | Sell |
|
|||||
|
2019
Q2 | $304M | Sell |
|
|||||
|
2019
Q1 | $816M | Sell |
|
|||||
|
2018
Q4 | $777M | Sell |
|
|||||
|
2018
Q3 | $880M | Sell |
|
|||||
|
2018
Q2 | $795M | Sell |
|
|||||
|
2018
Q1 | $828M | Sell |
|
|||||
|
2017
Q4 | $961M | Sell |
|
|||||
|
2017
Q3 | $1.18B | Sell |
|
|||||
|
2017
Q2 | $1.37B | Sell |
|
|||||
|
2017
Q1 | $1.14B | Buy |
|
|||||
|
2016
Q4 | $845M | Sell |
|
|||||
|
2016
Q3 | $1B | Sell |
|
|||||
|
2016
Q2 | $929M | Sell |
|
|||||
|
2016
Q1 | $1.22B | Sell |
|
|||||
|
2015
Q4 | $2.01B | Sell |
|
|||||
|
2015
Q3 | $1.92B | Sell |
|
|||||
|
2015
Q2 | $2.15B | Sell |
|
|||||
|
2015
Q1 | $2.26B | Buy |
|
|||||
|
2014
Q4 | $2.05B | Buy |
|
|||||
|
2014
Q3 | $1.79B | Buy |
|
|||||
|
2014
Q2 | $1.39B | Buy |
|
|||||
|
2014
Q1 | $1.2B | Buy |
|
|||||
|
2013
Q4 | $1.03B | Sell |
|
|||||
|
2013
Q3 | $1.18B | Buy |
|
|||||
|
2013
Q2 | $706M | Buy |
|